Abstract:Previously, we have reported that siRNA-mediated survivin inhibition could enhance in vitro chemo- or radiosensitivity of colorectal cancer (CRC) cells. The aim of this study was to investigate whether that small interfering RNA (siRNA) targeting survivin could enhance in vivo chemo- or radiosensitivity of colorectal cancer cells.pSilencer4.1-shRNA targeting survivin (pSilencer4.1-s) and pSilencer4.1-NC (negative control) vectors were previously constructed by us. Two colorectal cancer cell lines (LoVo or HCT-8) were collected and used for forming subcutaneous tumors in nude mice. Then, the tumors were intratumorally injected with pSilencer4.1-s or pSilencer4.1-NC vectors combined with chemotherapy (5-FU) or radiotherapy (6Gy). Firstly, the expression of survivin mRNA and protein in tumors treated with pSilencer4.1-s or pSilencer4.1-NC alone was detected by RT-PCR and Western blotting or immunohistochemistry assays. Next, the tumor volumes were recorded. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to detect apoptosis of tumor cells and the activity of caspase-3 was detected.The expression of survivin mRNA and protein in tumor tissues treated with pSilencer4.1-s was significantly downregulated (p < 0.05). The immunostaining of survivin protein was also significantly weaker in tumor tissues treated with pSilencer4.1-s. Moreover, the volumes of the nude mice treated with pSilencer4.1-s and chemo- or radiotherapy decreased markedly compared with those of the mock- or pSilencer4.1NC-treated control combined with chemo- or radiotherapy. The apoptosis of tumor tissue cells treated with pSilencer4.1-s and chemo- or radiotherapy could be significantly increased compared with the mock- or pSilencer4.1-NC-treated control combined with chemo- or radiotherapy (p < 0.05), which might be associated with the active Caspase-3 pathway.siRNA-mediated survivin inhibition could enhance in vivo chemo- or radiosensitivity of CRC cells. Accordingly, the survivin gene might be a potential target for the chemoradiotherapy of CRC.

Targeted Silencing of Artemis Enhanced Radiosensitivity in Human Colorectal Cancer Cells

Silencing Artemis Enhances Colorectal Cancer Cell Sensitivity to DNA-Damaging Agents.

Developing a Peptide That Inhibits DNA Repair by Blocking the Binding of Artemis and DNA Ligase IV to Enhance Tumor Radiosensitivity.

The Dominant Negative Mutant Artemis Enhances Tumor Cell Radiosensitivity

Effects of selective inactivation of DNA-PKcs gene with small interfering RNA on radiosensitivity of human pancreatic carcinoma cell line

[Silencing of Adrm1 by RNA Interference Suppresses Proliferation of Colorectal Cancer Cells].

Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer

Selective Radiosensitization of Human Cervical Cancer Cells and Normal Cells by Artemisinin Through the Abrogation of Radiation-Induced G2 Block

Peer Review #1 of "radiosensitization Effect of Hsa-Mir-138-2-3p on Human Laryngeal Cancer Stem Cells (V0.2)"

Artemin Stimulates Radio- and Chemo-Resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-Like Behavior in Mammary Carcinoma Cells.

Enhancing the radiosensitivity of colorectal cancer cells by reducing spermine synthase through promoting autophagy and DNA damage

Knockdown of the Novel Proteasome Subunit Adrm1 Located on the 20q13 Amplicon Inhibits Colorectal Cancer Cell Migration, Survival and Tumorigenicity.

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma.

Artemis Regulates Cell Cycle Recovery from the S Phase Checkpoint by Promoting Degradation of Cyclin E

A study of radiosensitizing effect of PKM2 silencing in lung adenocarcinoma cells and xenografts

Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells Through Specific Regulation of Cd24

Knockdown of TRIM31 Enhances Colorectal Cancer Radiosensitivity by Inducing DNA Damage and Activating Apoptosis

SiRNA-mediated Survivin Inhibition Enhances Chemo- or Radiosensivity of Colorectal Cancer Cells in Tumor-Bearing Nude Mice.

Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy

Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells

Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression